Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal
Merck will pay Hansoh $112 million upfront for rights to the drug, with the potential for an additional $1.9 billion
Read MoreMerck will pay Hansoh $112 million upfront for rights to the drug, with the potential for an additional $1.9 billion
Read MoreAmid a downbeat outlook for Europe, analysts say there could be some bright spots to watch out for in 2025.
Read MoreThe active ingredient in Ozempic was associated with a 40% to 70% lower risk of a first-time Alzheimer's diagnosis in
Read MoreThe agency said it would now allow compounding pharmacies and facilities to provide the drugs while it reviews if there
Read MoreHealth-care costs are going up, and yet workers may still not get the coverage they want — particularly when it
Read MoreDanish biotech Zealand Pharma is targeting the "next generation" of weight loss drugs as competitors pile into a market dominated
Read MoreInvestors who want to diversify away from popular names and themes can look at this sector, says Morgan Stanley Investment
Read MoreBooming demand for blockbuster weight-loss drugs like Ozempic and Mounjaro is being tested by a ports strike hitting import hubs
Read MoreILA union longshoremen at East Coast, Gulf Coast ports walk off the job after ownership and labor failed to reach
Read More